Used in the synthesis of pharmaceuticals, particularly as a chiral intermediate in the production of active pharmaceutical ingredients (APIs) for central nervous system agents. It serves as a building block in the development of antidepressants and other psychotropic drugs due to its structural similarity to known bioactive molecules. Its chiral center allows for selective interactions in biological systems, making it valuable in asymmetric synthesis. Also employed in research settings for developing novel amine-containing compounds with potential therapeutic effects.